ABU SHERIFF: Open Payments
NPI 1043764632 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 38 payments from 11 companies in 2025. Trend: 2023 $623 · 2024 $954 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $258 |
| Novo Nordisk Inc | 8 | $221 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| Boston Scientific Corporation | 2 | $74 |
| ABBVIE INC. | 3 | $74 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Abbott Laboratories | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: MOUNJARO, AIRSUPRA, Ozempic, Rybelsus, QULIPTA, General - Pain Management, Wegovy, Kerendia.
Industry payments across VA — which companies pay providers there.
